Peri-/Postoperative antientzündliche Therapie im Rahmen von vitreoretinalen Eingriffen

Zusammenfassung

Die perioperative Behandlung netzhautchirurgischer Eingriffe mit entzündungshemmenden Medikamenten ist für Augenärzte in Deutschland eine alltägliche Maßnahme. Trotzdem liegen erstaunlich wenige Daten vor, die eine Wirksamkeit nach vitreoretinaler Chirurgie untersuchen. Behandelt wird i. d. R. in Analogie zu Eingriffen am vorderen Augenabschnitt, für die wesentlich robustere Daten vorliegen. In diesem Beitrag sollen die relevanten klinischen Fragen beantwortet und soweit möglich, mit Studiendaten belegt werden.

Abstract

The perioperative treatment of retinal surgery with anti-inflammatory drugs is an everyday procedure for ophthalmologists in Germany. Nevertheless, little data are available to investigate the efficacy of vitreoretinal surgery. Treatment is usually analogous to procedures on the anterior segment of the eye, for which much more robust data are available. In this article, the relevant clinical questions will be answered and, when possible, documented with study data.

Schlüsselwörter

Steroide - Ablatio retinae - Inflammation - Makula - Netzhaut

Key words

steroids - retinal detachment - inflammation - macula - retina

• Literatur

• 1 Hoshi S, Okamoto F, Hasegawa Y. et al. Time course of changes in aqueous flare intensity after vitrectomy for rhegmatogenous retinal detachment. Retina (Philadelphia, Pa) 2012; 32: 1862-1867
• 2 Ramulu PY, Do DV, Corcoran KJ. et al. Use of retinal procedures in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol 2010; 128: 1335-1340
• 3 Aptel F, Colin C, Kaderli S. et al. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol 2017; 101: 1-10
• 4 Chalam KV, Malkani S, Shah VA. Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery. Ophthalmic Surg Lasers Imaging 2003; 34: 188-192
• 5 Hoerster R, Hermann MM, Rosentreter A. et al. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment. Br J Ophthalmol 2013; 97: 450-453
• 6 Schaub F, Hoerster R, Schiller P. et al. Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial. Trials 2018; 19: 384
• 7 Kim SJ, Lo WR, Hubbard GB. et al. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. Arch Ophthalmol 2008; 126: 1203-1208
• 8 Naithani P, Puranik S, Vashisht N. et al. Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery. Retina (Philadelphia, Pa) 2012; 32: 250-255
• 9 Ben Yahia S, Kahloun R, Abroug N. et al. Comparative effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment surgery. Int Ophthalmol 2016; 36: 623-628
• 10 Nagpal M, Lambat S, Mehrotra N. et al. Topical nepafenac 0.1 % alone versus prednisolone acetate 1 % as postoperative anti-inflammatory agents in small gauge vitrectomy. Indian J Ophthalmol 2014; 62: 606-609
• 11 Heier JS, Awh CC, Busbee BG. et al. Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4 %, bromfenac 0.09 %, and nepafenac 0.1 %. Retina (Philadelphia, Pa) 2009; 29: 1310-1313
• 12 Burton TC, Stevens TS, Harrison TJ. The influence of subconjunctival depot corticosteroid on choroidal detachment following retinal detachment surgery. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1975; 79: OP845-9
• 13 Weijtens O, Feron EJ, Schoemaker RC. et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol 1999; 128: 192-197
• 14 Paccola L, Jorge R, Barbosa JC. et al. Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1 % eyedrops after pars plana vitrectomy. Acta Ophthalmol Scand 2007; 85: 603-608
• 15 Mardin C. Perioperative Therapie. In: Erb C, Schlote T. Medikamentöse Augentherapie. 6. Aufl.. Stuttgart: Thieme; 2016: 535-548
• 16 Yamakiri K, Sakamoto T, Noda Y. et al. One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 959-966
• 17 Jaissle GB, Szurman P, Völker M. et al. Epiretinal deposit of triamcinolone acetonide at the posterior pole after intravitreal injection. Ophthalmic Surg Lasers Imaging 2007; 38: 238-241
• 18 Pastor JC, Rojas J, Pastor-Idoate S. et al. Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res 2016; 51: 125-155
• 19 Conart JB, Kurun S, Ameloot F. et al. Validity of aqueous flare measurement in predicting proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Acta Ophthalmol 2017; 95: e278-e283
• 20 Schröder S, Muether PS, Caramoy A. et al. Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Retina (Philadelphia, Pa) 2012; 32: 38-42
• 21 Koerner F, Koerner-Stiefbold U, Garweg JG. Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial. Graefes Arch Clin Exp Ophthalmol 2012; 250: 981-987
• 22 Ritter M, Sacu S, Matt G. et al. Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane: a randomized, controlled clinical study. Eye (Lond) 2011; 25: 1284-1293
• 23 Rezar S, Sacu S, Ritter M. et al. [Influence of postoperative oral steroid treatment on retinal sensitivity in patients after macular surgery. A randomized, controlled, clinical trial]. Ophthalmologe 2014; 111: 31-36
• 24 Huang OS, Mehta JS, Htoon HM. et al. Incidence and risk factors of elevated intraocular pressure following deep anterior lamellar keratoplasty. Am J Ophthalmol 2016; 170: 153-160
• 25 Baartman BJ, Gans R, Goshe J. Prednisolone versus dexamethasone for prevention of pseudophakic cystoid macular edema. Can J Ophthalmol 2018; 53: 131-134
• 26 Ostrov CS, Sirkin SR, Deutsch WE. et al. Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clin Ther 1997; 19: 259-272
• 27 Awan MA, Agarwal PK, Watson DG. et al. Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance. Br J Ophthalmol 2009; 93: 708-713